IDiyas

For the Inventor, By the Inventor

Durham, NC, United States of America

Stephen Thomas Davis

USPTO Granted Patents = 18 

 

Average Co-Inventor Count = 6.0

ph-index = 7

Forward Citations = 218(Granted Patents)


Company Filing History:

goldMedal10 out of 49 
 
Transtech Pharma, Inc.
 patents
silverMedal4 out of 2,198 
 
Smithkline Beecham Corporation
 patents
bronzeMedal2 out of 52 
 
Vtv Therapeutics LLC
 patents
4. 1 out of 281 
 
Glaxo Wellcome Inc.
 patents
5. 1 out of 50 
 
High Point Pharmaceuticals, LLC
 patents

Years Active: 2002-2015

Loading Chart...
Loading Chart...
18 patents (USPTO):
1. 9175003 - Substituted azoanthracene derivatives and intermediates for preparation thereof (2015-11-03),
2. 9120813 - Oxadiazoanthracene compounds for the treatment of diabetes (2015-09-01),
3. 8987295 - Substituted azoanthracene derivatives, pharmaceutical compositions, and methods of use thereof (2015-03-24),
4. 8933222 - Oxadiazoanthracene compounds for the treatment of diabetes (2015-01-13),
5. 8703766 - Oxadiazoanthracene compounds for the treatment of diabetes (2014-04-22),
6. 8524708 - Oxadiazoanthracene compounds for the treatment of diabetes (2013-09-03),
7. 8383644 - Substituted azoanthracene derivatives, pharmaceutical compositions, and methods of use thereof (2013-02-26),
8. 8377983 - Benzazole derivatives, compositions, and methods of use as aurora kinase inhibitors (2013-02-19),
9. 7906507 - Oxadiazoanthracene compounds for the treatment of diabetes (2011-03-15),
10. 7820821 - Benzazole derivatives, compositions, and methods of use as aurora kinase inhibitors (2010-10-26),
11. 7790714 - Oxadiazoanthracene compounds for the treatment of diabetes (2010-09-07),
12. 7727983 - Oxadiazoanthracene compounds for the treatment of diabetes (2010-06-01),
13. 7582673 - Bissulfonamide compounds as agonists of GalR1, compositions, and methods of use (2009-09-01),
14. 7105529 - Substituted oxindole derivatives as protein tyrosine and as protein serine/threonine kinase inhibitors and compositions and methods of treating chemotherapy and radiation therapy side effects (2006-09-12),
15. 6620818 - Method for reducing the severity of side effects of chemotherapy and/or radiation therapy (2003-09-16),

Title: The Innovative Journey of Stephen Thomas Davis

Introduction: Stephen Thomas Davis, a pioneering inventor based in Durham, NC, has made significant contributions to the field of technology through his groundbreaking inventions and patents.

Latest Patents: Stephen Thomas Davis holds several patents in various technological domains, including artificial intelligence, renewable energy, and medical devices. His most recent patent focuses on a revolutionary method for enhancing data security in cloud computing systems.

Career Highlights: With a career spanning over two decades, Stephen Thomas Davis has established himself as a leading figure in the tech industry. His innovative solutions have not only improved efficiency in various sectors but have also set new standards for technological advancement.

Collaborations: Throughout his career, Stephen Thomas Davis has collaborated with top research institutions, leading companies, and brilliant minds in the industry. These collaborations have resulted in the development of cutting-edge technologies that have had a profound impact on society.

Conclusion: Stephen Thomas Davis's relentless pursuit of innovation and his passion for pushing the boundaries of technology have solidified his position as a visionary inventor. His work continues to inspire the next generation of inventors and shape the future of technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…